Lexeo Therapeutics, Inc. (LXEO) is trading at $3.39, up 23.25 percent or $0.68 during Monday's trading, despite reporting a widened net loss of $25.9 million for the fourth quarter compared to $14.2 million in the prior period.
The stock opened at $2.99 and has traded between $2.99 and $3.98 so far, compared to a previous close of $2.71 on the Nasdaq. Trading volume is 4.16 million shares, significantly above the average of 342,756. The stock's 52-week range is $2.32 to $19.50.
For comments and feedback: editorial@rttnews.com